- Joined
- Jul 29, 2004
- Messages
- 605
- Reaction score
- 135
I keep noticing some bold moves by both Quest and Labcorp eating up hospital lab services. Are we all destined to be their employees at this rate? This is a very concerning trend and I don't see a good way to defend against it. I've been impacted twice now. I recently left a job where Quest bought out all the outpatient work, only to start work at another hospital system, who subsequently sold out to Labcorp within the same year.
"First, Ascension will sell its hospital laboratory outreach business at a number of locations to Labcorp. Second, Labcorp will manage the inpatient laboratories of many Ascension hospitals."
"In managing inpatient labs, Labcorp is in a position to direct tissue specimens to its own pathologists, particularly the more complex cancer cases that require extensive workups and multiple diagnostic procedures. That would reduce case referrals to the local pathology groups currently serving Ascension hospitals."
"The company’s free cash flow for 2021 was $2.6 billion. A substantial portion of that free cash flow was generated by COVID-19 testing. For that reason, Labcorp has a big war chest of cash it can use to go out and do more deals with hospitals and health systems."
www.darkintelligencegroup.com
"First, Ascension will sell its hospital laboratory outreach business at a number of locations to Labcorp. Second, Labcorp will manage the inpatient laboratories of many Ascension hospitals."
"In managing inpatient labs, Labcorp is in a position to direct tissue specimens to its own pathologists, particularly the more complex cancer cases that require extensive workups and multiple diagnostic procedures. That would reduce case referrals to the local pathology groups currently serving Ascension hospitals."
"The company’s free cash flow for 2021 was $2.6 billion. A substantial portion of that free cash flow was generated by COVID-19 testing. For that reason, Labcorp has a big war chest of cash it can use to go out and do more deals with hospitals and health systems."
- In 2017, Labcorp bought the lab outreach business of Mount Sinai Health System in New York City. (See TDR, Jan. 30, 2017.)
- In 2013, the owners of Genesis Clinical Laboratory in Berwyn, Ill., sold their lab outreach business to Labcorp. (See TDR, July 29, 2013.)
- In 2020, it acquired the clinical ambulatory laboratory business of Franciscan Missionaries of Our Lady Health System in Baton Rouge, La. (See TDR, Sept. 14, 2020.)
Labcorp to Buy Outreach, Manage Ascension Labs
This is the largest lab transaction in 50 years involving a major healthcare system and a big commercial lab.
